VanEck Biotech ETF
BBH
39 hedge funds and large institutions have $91.9M invested in VanEck Biotech ETF in 2013 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 3 closing their positions.
330% more call options, than puts
Call options by funds: $4.2M | Put options by funds: $976K
100% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 9
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
44% more capital invested
Capital invested by funds: $63.8M → $91.9M (+$28.1M)
3% more funds holding
Funds holding: 38 → 39 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.39% less ownership
Funds ownership: 22.71% → 21.31% (-1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$7.73M |
| 2 |
U
UBS
Zurich,
Switzerland
|
+$1.83M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.72M |
| 4 |
MCM
Murphy Capital Management
Bedminster,
New Jersey
|
+$1.7M |
| 5 |
WJA
Williams Jones & Associates
New York
|
+$1.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FMI
Factory Mutual Insurance
Waltham,
Massachusetts
|
-$1.57M |
| 2 |
NCM
Niemann Capital Management
Stateline,
Nevada
|
-$1.19M |
| 3 |
Goldman Sachs
New York
|
-$775K |
| 4 |
UAS
United Asset Strategies
Garden City,
New York
|
-$333K |
| 5 |
Bank of New York Mellon
New York
|
-$278K |
BBH Hedge Fund Activity: Q3 2013 in Review
39 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2013, worth a combined $91.9M — up 44% from $63.8M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BBH positions and 3 closed out — a net gain of 2 holders — while 18 added to existing stakes and 9 trimmed.
The largest buyer was Citigroup, adding an estimated $7.73M. The largest seller was Factory Mutual Insurance, cutting an estimated $1.57M.
- 39 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2013, up from 38 in Q2 2013.
- Funds reported $91.9M of VanEck Biotech ETF stock for Q3 2013, up 44% quarter-over-quarter.
- 5 funds opened new VanEck Biotech ETF positions in Q3 2013 and 3 closed out, a net change of +2 holders.
- The largest VanEck Biotech ETF buyer in Q3 2013 was Citigroup, an estimated $7.73M added.
- The largest VanEck Biotech ETF seller in Q3 2013 was Factory Mutual Insurance, an estimated $1.57M sold.
Based on aggregated 13F filings for Q3 2013.